Thus, inhibiting the DKK1-CKAP4 and MEK-ERK pathways simultaneously may provide a new strategy of the treatment for PDAC and ESCC expressing DKK1 and FOXM1. Here, DKK1 is linked to esophageal squamous cell carcinoma.